Toxoplasma gondii infection in patients with lung diseases in Shandong province, eastern China

Yong-Xin Li,Cui-Ying Wei,Xiang-Yan Zhang,Yu-He Duan,Pi-Ning Zhang,Ming-Jin Guo,Hai-Tao Niu,Ming-jin Guo
DOI: https://doi.org/10.1016/j.actatropica.2020.105554
IF: 3.222
2020-11-01
Acta Tropica
Abstract:<p><em>Toxoplasma gondii</em>, an intracellular protozoan parasite, can induce various clinical symptoms. <em>T. gondii</em> has been considered to play an important role in the pathogenesis of lung diseases. This survey was conducted to explore the correlation between <em>T. gondii</em> infection and lung diseases through a case-control study carried out in Shandong province, eastern China. In the present survey, <em>T. gondii</em> IgG antibodies were found in 76/398 (19.10%) of patients with lung diseases, which was significantly higher (<em>P</em> &lt; 0.001) than the level found in the control subjects (35/398; 8.79%) through serological diagnosis. Patients with lung cancer have the highest <em>T. gondii</em> seroprevalence (26.19%), followed by Pulmonary cyst (25.00%), Tuberculosis (17.07%), Pneumonia (16.33%) and chronic obstructive pulmonary disease (COPD) (16.05%). Moreover, a semi-nest PCR targeted <em>T. gondii</em> B1 gene was employed to detect the <em>T. gondii</em> DNA in the blood samples. <em>T. gondii</em> DNA was detected in 5.53% blood samples of patients with lung diseases and 2.51% control subjects, respectively. The present study firstly shows that <em>T. gondii</em> has a high probability to infect the patients with lung diseases. Thus, the potential presence of <em>T. gondii</em> in patients with lung diseases should be appreciated during in the course of treatment and safeguard procedures should be implemented to protect vulnerable patients with lung diseases.</p>
tropical medicine,parasitology
What problem does this paper attempt to address?